Back to Search
STEPHEN TOMEK, MD
MD
Pediatric Critical Care Medicine Physician
NPI: 1295762375Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
076507(GA)
Pediatric Critical Care Medicine PhysicianPrimary
Pediatrics — Pediatric Critical Care Medicine
Code: 2080P0203X
076507(GA)
Research & Publications (20)
A prospective, open label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first line chemotherapy in patients with androgen independent prostate cancer.
PMID 17509302·J Urol·2007
3-trial
11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer.
PMID 16636343·J Clin Oncol·2006
8-other
Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.
PMID 15972852·Mol Cancer Res·2005
8-other
Common death receptor 4 (DR4) polymorphisms do not predispose to ovarian cancer.
PMID 15863153·Gynecol Oncol·2005
8-other
Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.
PMID 15262127·Gynecol Oncol·2004
8-other
Chemotherapy for malignant pleural mesothelioma: past results and recent developments.
PMID 15261443·Lung Cancer·2004
6-review
Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer.
PMID 15014012·Clin Cancer Res·2004
8-other
Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines.
PMID 12763223·Eur J Cancer·2003
8-other
Chemotherapy for malignant pleural mesothelioma: past results and recent developments.
PMID 12610498·Br J Cancer·2003
6-review
[Acceptance of and satisfaction with medical information provided to cancer patients].
PMID 11388081·Wien Klin Wochenschr·2001
8-other
Soluble ICAM-1 in breast cancer: clinical significance and biological implications.
PMID 11761443·Cancer Immunol Immunother·2001
4-observational
Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status.
PMID 11742500·Br J Cancer·2001
8-other
Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial.
PMID 11697841·Ann Oncol·2001
3-trial
Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer.
PMID 11081453·Anticancer Drugs·2000
3-trial
Phase II study of second-line oxaliplatin, irinotecan and mitomycin C in patients with advanced or metastatic colorectal cancer.
PMID 11081454·Anticancer Drugs·2000
3-trial
Single-agent gemcitabine as second- and third-line treatment in metastatic breast cancer.
PMID 14965758·Breast·2000
8-other
Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancer.
PMID 10831273·Anticancer Drugs·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1720 UNIVERSITY DR S
FARGO, ND 58103 - Phone
- (701) 234-2000
Quick Facts
- NPI
- 1295762375
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile